End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,822 ARS | +0.92% | -3.33% | +40.46% |
29/05 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
29/05 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 8.89 and 8.61 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+40.46% | 7.8TCr | - | ||
-7.71% | 6.35TCr | B | ||
+22.14% | 5TCr | A- | ||
-1.96% | 699.61Cr | A- | ||
-16.76% | 532.98Cr | A- | ||
-5.25% | 242.88Cr | C- | ||
-6.52% | 224.85Cr | C- | ||
-36.61% | 151.22Cr | - | ||
-2.82% | 130.02Cr | D+ | ||
-17.39% | 116.48Cr | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MO Stock
- MO Stock
- Ratings Altria Group, Inc.